58
ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran 1

ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Embed Size (px)

Citation preview

Page 1: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 1

ANAPHYLAXIS&

Allergic Reactions

DR. ALISAN YILDIRAN

b

Page 2: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 2

• In 1796, Jenner reported smallpox vaccine

Page 3: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 3

Von Pirquet -1905

• Defined – ALLERGY– Serum Disease– Mantoux test

Page 4: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 4

Richet-1913

• Defined Anapylaxy• Nobel laureate

Page 5: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

IMMUNE SYSTEM

Dr. Yıldıran 5

Abbas, 2004

Abbas, 2004

Antigen presenting cell/DCPROTEIN

Page 6: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 6

IL-5

Complement activation

Mast celldegranulation

Mucosal immunity

Page 7: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Allergy - Atopy

Dr. Yıldıran 7Abbas, 2012

Page 8: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 8

Revised nomenclature

Anaphylaxis

ALLERGIC NON-ALLERGIC

IgE- mediated non-IgE-mediated

Johansson SGO et al JACI 2004,113:832-6

Page 9: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 9

Hypersensitivity

Type I Immediate hypersensitivityType II Cytotoxic reactionsType III Immune complex reactionsType IV Delayed hypersensitivity

Anaphylaxis can occur through Types I, II and III immunopathologic mechanisms

Kemp SF and Lockey RF. J Allergy Clin Immunol 2002;110:341-8

Page 10: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 10

3 to 6 hours

(CysLTs, PAF,IL-5)

Mast cell

Allergen

Cellular infiltrates: 3 to 6 hours (LPR)

PGs

Return of

Symptoms

Histamine IL-4, IL-6

EosinophilCysLTs, GM-CSF, TNF-, IL-1, IL-3, PAF, ECP, MBP

Proteases

CysLTs

BasophilHistamine,CysLTs,TNF-, IL-4, IL-5, IL-6

MonocyteCysLTs, TNF-, PAF, IL-1

Lymphocyte

IL-4, IL-13, IL-5, IL-3, GM-CSFEPR 15 min

Biphasic/late-phase reaction

(Early-Phase Reaction)

Page 11: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 11

Definitions

• Anaphylaxis: a severe systemic allergic reaction involving 2 or more systems* hives/angioedema NOT universally present!

• Anaphylactic Shock: above, plus hypotension and other signs of shock

• Allergic reactions: localized reaction, involving a single system; e.g. urticaria, angioedema, contact dermatitis, rhinoconjunctivitis

Page 12: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 12

Anaphylactic vs. Anaphylactoid

• Anaphylactoid has the same clinical features as anaphylaxis but is not IgE mediated

• Instead it is due to direct mast cell degranulation and thus, does not require prior sensitization

Page 13: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 13

Differential diagnosis

• Vasovagal reactions

• Flushing

• Mastocytosis

• Carcinoid syndrome

• Hyperventilation syndrome

• Globus hystericus

• Hereditary angioedema

• Other types of shock, eg. cardiogenic, septic

• Scombroid poisoning Montanaro A and Bardana EJ Jr. J Investig Allergol Clin Immunol 2002;12:2-11

Page 14: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 14

IgE-dependent triggers

• Foods• Medications • Venoms• Latex• Allergen immunotherapy

• Diagnostic allergens

• Exercise

• Hormones

• Animal or human proteins

• Colorants (insect-derived, eg. carmine)

• Enzymes

• Polysaccharides

• Aspirin and NSAIDs (possibly through IgE)

Kemp SF and Lockey RF, J Allergy Clin Immunol 2002;110:341-8

Page 15: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 15

Hymenoptera stings

• 0.5% to 5% of the US population is allergic to

Hymenoptera venom(s)- bees- wasps- yellow jackets- hornets- fire ants

• at least 50 deaths per year

• incidence rising due to increased numbers of fire ants and

Africanized beesNeugut AI et al. Arch Intern Med 2001;161:15-21

Page 16: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 16

Immune causes other than IgE

• Cytotoxic (Type II)

- transfusion reactions to cellular elements

(IgG, IgM)

• Immune aggregates (Type III)

- Intravenous immunoglobulin

- Dextran (possibly)

Kemp SF and Lockey RF, J Allergy Clin Immunol 2002;110:341-8

Page 17: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 17

• Radiocontrast media

• Ethylene oxide gas on dialysis tubing (possibly through

IgE)

• Protamine (possibly)

• ACE-inhibitor administered during renal dialysis

MULTIMEDIATOR COMPLEMENT ACTIVATION/ACTIVATIONOF CONTACT SYSTEM

Non-immunologic causes

Kemp SF and Lockey RF, J Allergy Clin Immunol 2002;110:341-8

Page 18: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 18

Non-immunologic causes

NONSPECIFIC DEGRANULATION OF MAST CELLS AND BASOPHILS

• Opiates

• Physical factors:

- Exercise (no food or medication co-trigger)

- Temperature (cold, heat)

Kemp SF and Lockey RF, J Allergy Clin Immunol 2002;110:341-8

Page 19: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 19

Idiopathic anaphylaxis

• Common in adults

• Uncommon in children

• Negative skin tests, negative dietary history, no

associated diseases eg. Mastocytosis

• Preventive medication: oral corticosteroids, H1 & H2

antihistamines, anti-leukotrienes

• Deaths rare

• May gradually improve over time

Lieberman PL et al. J Allergy Clin Immunol 2005;115:S483-S523

Page 20: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 20

Epidemiology

• Likely under reported due to lack of recognition or self treatment in the field

• in Ontario: 4 cases/ 1 million• in Germany: 10 cases/100 000• in Minnesota, U.S.A.: 17/19,122 visits• in Brisbane, Australia: 1/440 visits

Page 21: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 21

Grading of AnaphylaxisGrad

eSkin GI tract Resp CV Neur

o1 Local

pruritus, hives, mild lip swelling

Oral “tingling”, pruritus

2 Generalized pruritus, hives, flushing, angioedema

Above plus nausea +/- emesis

Nasal congestion/sneezing

Activity change

3 Any of above Any of above + repetitive vomiting

Rhinorrhea, sensation of throat tightness

Tachy( > 15 bpm)

Above plus anxiety

4 Any of above Any of above + diarrhea

Hoarsenessdysphagia, SOB, cyanosis

Above + arrhythmia +/- dec BP

dizzinessFeeling of impending doom

5 Any of above Any above + stool incont.

Any above + resp arrest

Brady +/- card arrest

LOC

Page 22: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 22

Anaphylaxis in Infants

In infants with anaphylaxis, respiratory compromise is more likely than hypotension or shock, and shock is more likely to manifest initially as tachycardia rather than hypotension.

Page 23: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 23

Key Management of Anaphylaxis

1st line of therapy:

• AWARENESS• RECOGNITION• TREAT QUICKLY• CALL FOR BACK-UP!

Page 24: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 24

Anaphylaxis Algorithm

Anaphylaxis:(Hypotension with/without respiratory obstruction)Eg: SBP<90 +/ - stridor, tongue/ laryngeal swelling

• 0.1 mg epinephrine in 10 ml NS IV over 10 minutes! (Dilute 0.1 ml of 1:1,000 f rom 1mg/ ml amp in 10 ml NS or 1 ml of 1:10,000 f rom 1mg/ 10 ml in 10 ml NS & run @ 1 mcg/ min; total 10 mcg)

• Benadryl 50 mg IV/PO &• Ranitidine 50 mg IV or 150 mg PO &• Prednisone 50 mg PO (or Solumedrol 125 mg IV)• +/- Ventolin 2cc nebulized q 5 min X 3 prn

Systemic Allergic Reaction:(angioedema or bronchospasm)

Simple Allergic Reaction:(urticaria, GI upset, contact dermatitis)

0.3 mg (0.3 ml) 1: 1,000 epinephrine IM* (1mg/ml amp)

Cardiac Monitor + 1 L NS bolus

Repeat 1L NS bolus, if no response

Repeat IM epinephrine & add ventolin 2 cc via neb

ABCs

Least severeMost severe

All three groups of patients receive the following:

Hypotension persists No or inadequate response * never use SC due to inconsistent absorption•I n pts on Bblockersbeware of poor response to epi; use Glucagon 1 mg IV/ IM instead.CALL FOR BACK-UP!

Anita Pozgay, MD.

Page 25: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 25

Adult Epi dosing

• Epinephrine:0.3 mg (0.3 ml) 1:1000 solution IM

(NOT SC or IV)may repeat in 5 min X 1

(empirical only but safe)

Page 26: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 26

Epi: Pediatric Dosing(0.01 ml/kg)

Age (yrs) Volume ofDose (mg)

1:1000(1mg/ml)

1 0.1 ml 0.12-3 0.2 ml 0.2> 4 0.3 ml 0.3

Page 27: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 27

EPI cautions: Co-morbidities

• Thyroid disease• Cocaine addicts• CAD on BBlockers, ACEi• Depression using MAOIs or TCAs

Page 28: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 28

Mechanisms of Epinephrine

• Alpha agonist effects – increase peripheral resistance, – raise BP, – reduce vascular leakage

• Beta agonist effects– bronchodilation, – positive cardiac inotropy/chronotropy (caution

in CAD )

Page 29: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 29

Dangers of Epinephrine IV

• Only use IV Epi if patient has refractory shock not responding to fluid bolus first

• Dose 0.1 mg (10 ml) 1:100,000 dilution over 10 minutes

• Must be on cardiac monitor• Caution in elderly or those with CAD• May cause supraventricular/ventricular

dysrhythmias!

Page 30: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 30

Do all patients need Epi?

Epinephrine reverses mediator release while antihistamines (H1) do not

Epinephrine should be used for all systemic signs of allergy: airway edema (includes tongue/lips), wheezing, cyanosis, hypotension

Page 31: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 31

Do all patients need steroids?

• Corticosteroids take 4-6 hours to work• theoretically blunt the multi-phasic

reaction of anaphylaxis• the quicker the onset of anaphylaxis the

worse the reaction/quicker resolution less likely to relapse

• Caution in IV steroids esp if given in bolus doses; case reports of anaphylaxis!

• Oral form preferred if possible

Page 32: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 32

Histamine Classes• H1 receptor: stimulates – Bronchial and intestinal smooth muscle contraction, – Vascular permeability, – Coronary artery spasm

• H2 receptor: increase – Rate & force of cardiac contraction, – Gastric acid secretion, – Airway secretions, – Vascular permeability, – Bronchodilation,

• H1 and H2 combination is more helpful on urticaria

Page 33: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 33

Management Refractory Anaphylaxis

Glucagon: increases inotropy/chronotropy & causes smooth muscle relaxation independent of B receptors

Dose: 1-5 mg in adults (0.5 - 1 mg in kids) IV/IM

Page 34: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 34

Disposition & Follow-up

• Inquire about possible antigen exposure• Those with systemic reactions require a

prescription for and instruction on how to use a EpiPen

• A Medic Alert Bracelet is useful• Follow-up with an allergist for skin

testing should be arranged particularly if the allergen is unknown

Page 35: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 35

EpiPen

Page 36: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 36

Infant protocol

Page 37: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 37

Infant protocol

Page 38: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 38

Exercise Induced Anaphylaxis

• Clinical features indistinguishable from allergen induced anaphylaxis

• Food dependent or independent forms • Mechanism not fully known, but thought

exercise lowers threshold for mast cell degranulation esp after a food allergen triggers an IgE response

Page 39: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 39

Urticaria versus Angioedema

• Both characterized by transient, pruritic, red wheals on raised serpiginous borders

• Urticaria due to edema of dermis• Angioedema due to edema of

subcutaneous tissues

Page 40: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 40

Urticaria

• Other name; Hives• Raised, well-circumscribed areas of

edema and erythema involving the dermis and epidermis

• Intensely pruritic• May be acute or chronic (>6 weeks)• Multiple types: IgE-mediated, chemical-

induced, cholinergic, cold-induced, autoimmune, etc.

Page 41: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 41

Page 42: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 42

Page 43: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 43

Page 44: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 44

Page 45: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 45

Pathophysiology

• Mast cells and basophils release histamine, bradykinin, leukotrienes, prostaglandins into the dermis– Causes fluid extravasation… leads to lesion

• Pruritis is due to histamine release into the dermis

• Multiple triggers: IgE mediated, others

Page 46: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 46

Causes

• Causes: found in 40-60% of acute urticaria, and 10-20% chronic urticaria

• Include:• Infections, pregnancy, other medical

conditions• Foods, drugs, latex• Environmental factors• Stress• Cold/heat, exercise

Page 47: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 47

History

• Previous episodes/causative factors• Medical history, medications, allergies• Possible precipitants:– Recent illness or travel– New medications or IV contrast– Foods, pets, exposures– Changes in perfumes, lotions, clothes– Exercise, temperature extremes, stress

Page 48: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 48

Physical Exam

• Identify and confirm urticarial diagnosis• Dermographism?• Look for precipitants/other illnesses:• Signs of infections: e.g. URTI, fungal infection• Signs of liver/thyroid disease• Angioedema, respiratory changes (edema,

wheezes)• Joint examination

• Ensure no signs of anaphylaxis are present

Page 49: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 49

Treatment

• REMOVE ANY RELEVANT TRIGGER!

Page 50: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 50

Treatment

• H1-blockers i.e. diphenhydramine, hydroxyzine

• H2-blockers i.e. ranitidine– Act synergistically with H1 blockers

• Doxepin 10-25mg tid-qid• Glucocorticoids e.g. prednisone– Stabilize mast cells, stopping histamine

release– Anti-inflammatory effect

Page 51: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 51

Angioedema

• Deep, subcutaneous, submucosal edema due to increased vascular permeability

• May be episodic and self-limited, or recurrent

• May involve skin, buccal mucosa/tongue, larynx or GI mucosa

• Usually presents with urticaria: mast-cell mediated in these cases

Page 52: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 52

Page 53: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 53

Page 54: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 54

Types

• Hereditary C1-esterase inhibitor deficiency

• Acquired: autoimmune/lymphoprolif. disorders

• Drug-induced (e.g. ACEI)• Urticaria-associated• Idiopathic (most cases)• Urticaria-associated is mast-cell mediated,

all others are kinin-mediated

Page 55: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 55

Clinical Features

CAPILLARY LEAK

• Urticaria• Angioedema• Laryngeal edema• Hypotension/syncope

SMOOTH MUSCLE CONTRACTION

• Abdominal cramps• Nausea• Rhinitis• Conjunctivitis

MUCOSAL SECRETIONS• Bronchospasm • Diarrhoea• Vomiting

Page 56: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 56

History

• Hereditary/idiopathic/drug-induced:– Episodic, self-limiting episodes of edema– Skin swelling, tongue swelling, abdominal

pain– Look for triggers

• Urticaria-associated:– Look for potential triggers: drugs, allergens,

food allergies, hymenoptera– History of atopy

Page 57: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 57

Physical Exam

• Acute onset of well-demarcated cutaneous edema of distensible tissues

• Usually face, limbs, genitals• Assess airway• Abdominal examination

Page 58: ANAPHYLAXIS & Allergic Reactions DR. ALISAN YILDIRAN b Dr. Yıldıran1

Dr. Yıldıran 58

Treatment

• AIRWAY management• Intubate early if any question

• Mild Angioedema• Remove offending agent; self-limited

• Severe Angioedema• H1, H2 blockers, corticosteroids• Epinephrine